Metabolic acidosis and elevated pyroglutamic acid in a patient with multiple organ dysfunction syndrome and chronic acetominophen use

Netherlands Journal of Critical Care

Volumn 12, Issue 5, 2008, Pages 213-215

  van Raalte, R ^a   Zandstra, D F ^a   van der Voort, P H J ^a  

^a Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALANINE AMINOTRANSFERASE; ALBUMIN; ALENDRONIC ACID; ALKALINE PHOSPHATASE; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CALCIUM CARBONATE; CREATININE; HYPERTENSIVE FACTOR; PARACETAMOL; PYROGLUTAMIC ACID; TEMAZEPAM; THIAMINE;

ABDOMINAL DISTENSION; ABDOMINAL PAIN; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANAMNESIS; ANION GAP; ARTERIAL BLOOD; ARTICLE; ARTIFICIAL VENTILATION; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; BLOOD GAS ANALYSIS; BREATHING RATE; CASE REPORT; CONFUSION; CONTINUOUS HEMOFILTRATION; CORE TEMPERATURE; CREATININE BLOOD LEVEL; DEATH; DIARRHEA; DRUG BLOOD LEVEL; FEMALE; FLUID RESUSCITATION; GLASGOW COMA SCALE; HEPATORENAL SYNDROME; HUMAN; JAUNDICE; LIVER FAILURE; METABOLIC ACIDOSIS; MULTIPLE ORGAN FAILURE; OXYGEN MASK; OXYGEN SATURATION; PARTIAL THROMBOPLASTIN TIME; PROTEIN BLOOD LEVEL; PROTHROMBIN TIME; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; WEAKNESS;

EID: 66249086190     PISSN: 15693511     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Gabow PA, Kaehny WD, Fennessey PV, Goodman SI, Gross PA, Schrier RW. Diagnostic importance of an increased serum anion gap. N Engl J Med 1980; 303:854-858.
2. Maciel AT, Park M. Unmeasured anions account for most of the metabolic acidosis in patients with hyperlactatemia. Clinics 2007; 62:55-62.
3. Moviat M, Terpstra AM, Ruitenbeek W, Kluijtmans LA, Pickkers P, van der Hoeven JG. Contribution of various metabolites to the "unmeasured" anions in critically ill patients with metabolic acidosis. Crit Care Med 2008; 36(3):752-758.
4. Pitt JJ, Brown GK, Clift V, Christodoulou J. Atypical pyroglutamic aciduria: possible role of paracetamol. J Inherit Metab Dis 1990; 13:755-756.
5. Pitt J. Association between paracetamol and pyroglutamic aciduria. Clin Chem 1990; 36:173-174.
6. Ghauri FY, McLean AE, Beales D, Wilson ID, Nicholson JK. Induction of 5-oxoprolinuria in the rat following chronic feeding with N-acetyl 4-aminophenol (paracetamol). Biochem Pharmacol 1993; 46:953-957.
7. Jackson AA, Persaud C, Werkmeister G, McClelland IS, Badaloo A, Forrester T. Comparison of urinary 5-L-oxoproline (L-pyroglutamate) during normal pregnancy in women in England and Jamaica. Br J Nutr 1997; 77:183-196.
8. Brooker G, Jeffery J, Nataraj T, Sair M, Ayling R. High anion gap metabolic acidosis secondary to pyroglutamic aciduria (5-oxoprolinuria): association with prescription drugs and malnutrition. Ann Clin Biochem 2007; 44(Pt 4):406-409.
9. Jackson AA, Badaloo AV, Forrester T, Hibbert JM, Persaud C. Urinary excretion of 5-oxoproline (pyroglutamic aciduria) as an index of glycine insufficiency in normal man. Br J Nutr 1987; 58:207-214.
10. Jackson AA, Persaud C, Meakins TS, Bundy R. Urinary excretion of 5-L-oxoproline (pyroglutamic acid) is increased in normal adults consuming vegetarian or low protein diets. J Nutr 1996; 126:2813-2822.
11. Lyons J, Rauh-Pfeiffer A, Ming-Yu Y, Lu XM, Zurakowski D, Curley M et al. Cysteine metabolism and whole blood glutathione synthesis in septic pediatric patients. Crit Care Med 2001; 29:870-877.
12. Griffith OW, Meister A. Glutathione: interorgan translocation, turnover, and metabolism. Proc Natl Acad Sci U S A 1979; 76:5606-5610.
13. Butera L, Feinfeld DA, Bhargava M. Sex differences in the subunits of glutathione-S-transferase isoenzyme from rat and human kidney. Enzyme 1990; 43:175-182.
14. Lauterburg BH, Velez ME. Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity. Gut 1988; 29:1153-1157.
15. Fenves AZ, Kirkpatrick HM, III, Patel VV, Sweetman L, Emmett M. Increased anion gap metabolic acidosis as a result of 5-oxoproline (pyroglutamic acid): a role for acetaminophen. Clin J Am Soc Nephrol 2006; 1(3):441-447.